Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide for Maintenance of Remission in Collagenous Colitis
NCT01278082Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Apr 2008
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of EPI-EE in collagenous colitis (CC), sponsored by Dr. Falk Pharma GmbH. Started Apr 2008; status: completed.
02
Drugs
EPI-EE
03
Conditions
collagenous colitis (CC)
Beyond the preview
Go deeper on NCT01278082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01278082.